Search results for: 'development both iot'

Although the telecoms landscape in APAC has changed a lot since the onset of the COVID-19 pandemic, data as a key driver of traffic and 5G monetization as the industry’s biggest bottleneck remain important trends impacting the industry. As 5G enterprise develops, enhanced mobile broadband (eMBB) is expected to continue to impact the mobile operator...

Strategic imperatives are concepts that companies embrace to overcome internal and external challenges, such as economic disruptions that make it difficult to prepare a company for the future. Frost & Sullivan has identified eight: 1. Innovative Business Models 2. Compression of Value Chains 3. Transformative Megatrends 4. Disruptive Techn...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

Frost & Sullivan defines non-licensed low-power wide-area network (LPWAN) connection as active devices connected to a wireless communication network designed for low-bandwidth, long-range data transmission over an unlicensed spectrum. This type of technology connects IoT devices with low power consumption and low data rates and covers large areas. ...

In the post-pandemic scenario, city governments invest in the effective use of data to deliver efficient urban transport systems, a cleaner environment, robust urban infrastructure, and improve city dwellers' overall quality of life. Frost & Sullivan's IoT Building Smart Cities: Growth Opportunities for IoT Start-ups is a resource to help the ecosy...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

Wearables IoT devices are small electronic devices with wireless communication capabilities incorporated into gadgets, accessories, clothes worn on the human body, or invasive equipment. Wearable IoT devices are gaining popularity globally as they have enhanced the consumers’ quality of life and convenience. The wearable IoT device testing marke...

The convergence of IoT and healthcare, known as the internet of medical things (IoMT), is transforming the healthcare landscape, bringing unprecedented connectivity and convenience. However, the rapid proliferation of IoT devices in healthcare exposes critical data security and cybersecurity risks. This Frost & Sullivan study explores data security...

The growing global demand for sustainable and ethical food sources has led to significant advancements in alternative proteins. From plant-based proteins to cellular agriculture and novel fermentation techniques, researchers and industry pioneers are leveraging biotechnology, data analytics, and process optimization to enhance the efficiency and sc...